Vor Biopharma (VOR) Interest & Investment Income (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Interest & Investment Income data on file, last reported at $3.9 million in Q1 2026.

• On a quarterly basis, Interest & Investment Income rose 388.82% year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was $9.0 million, a 153.18% increase from a year earlier, with the FY2025 full-year figure at $5.9 million, up 37.39% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $3.9 million, up from $2.8 million in the prior quarter.
• Over the last five years, Interest & Investment Income for VOR reached as high as $3.9 million in Q1 2026 and fell as low as $63000.0 in Q1 2022.
• Historically, Interest & Investment Income has averaged $1.4 million across 5 years, with a median of $1.2 million in 2024.
• Across the five-year window, Interest & Investment Income soared 3057.14% in 2023 and slumped 67.85% in 2024, its largest moves.
• Year by year, Interest & Investment Income stood at $815000.0 in 2022, then soared by 128.59% to $1.9 million in 2023, then slumped by 67.85% to $599000.0 in 2024, then soared by 366.61% to $2.8 million in 2025, then surged by 40.79% to $3.9 million in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $3.9 million in Q1 2026, $2.8 million in Q4 2025, and $1.7 million in Q3 2025.